|
DNAJB14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5204399999913E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.560800E-03 |
| Normal-vs-Stage2 |
1.678610E-01 |
| Normal-vs-Stage3 |
6.65970000257587E-08 |
| Normal-vs-Stage4 |
2.4633000084151E-09 |
| Stage1-vs-Stage2 |
8.624400E-01 |
| Stage1-vs-Stage3 |
1.403310E-04 |
| Stage1-vs-Stage4 |
1.6268399999908E-05 |
| Stage2-vs-Stage3 |
3.669600E-02 |
| Stage2-vs-Stage4 |
1.786240E-02 |
| Stage3-vs-Stage4 |
6.280600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75019999999671E-05 |
| Normal-vs-AfricanAmerican |
1.0358000002153E-07 |
| Normal-vs-Asian |
7.818400E-01 |
| Caucasian-vs-AfricanAmerican |
7.401400E-03 |
| Caucasian-vs-Asian |
3.044000E-01 |
| AfricanAmerican-vs-Asian |
2.211800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68023000000073E-05 |
| Normal-vs-Female |
3.783300E-04 |
| Male-vs-Female |
6.839000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.600000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.938340E-03 |
| Normal-vs-Age(61-80Yrs) |
1.44589999995226E-06 |
| Normal-vs-Age(81-100Yrs) |
1.079200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.302400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.272800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.389200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.565500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.473960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.113600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.055000E-01 |
| Normal-vs-Grade 2 |
1.253890E-02 |
| Normal-vs-Grade 3 |
3.98009999957871E-07 |
| Normal-vs-Grade 4 |
1.35730315875549E-11 |
| Grade 1-vs-Grade 2 |
5.527000E-01 |
| Grade 1-vs-Grade 3 |
4.902200E-02 |
| Grade 1-vs-Grade 4 |
2.953500E-04 |
| Grade 2-vs-Grade 3 |
7.400500E-03 |
| Grade 2-vs-Grade 4 |
1.75239999955501E-07 |
| Grade 3-vs-Grade 4 |
2.481200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.080610E-01 |
| Normal-vs-ccB subtype |
5.77680000000136E-05 |
| ccA subtype-vs-ccB subtype |
1.503720E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.405600E-04 |
| Normal-vs-N1 |
3.560500E-03 |
| N0-vs-N1 |
2.959200E-01 |
|
|
